| Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00118287) | Fred Hutchinson Cancer Center | 2005-04-01 |
| Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00118352) | Fred Hutchinson Cancer Center | 2005-03-01 |
| Usage of Acyclovir for Suppression of HIV-1 and HSV-2 Coinfected Persons in Cameroon (NCT00209313) | Fred Hutchinson Cancer Center | 2005-03-01 |
| Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia (NCT00110058) | Fred Hutchinson Cancer Center | 2005-02-01 |
| Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia (NCT00107523) | Fred Hutchinson Cancer Center | 2005-01-01 |
| Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00110071) | Fred Hutchinson Cancer Center | 2005-01-01 |
| Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00104858) | Fred Hutchinson Cancer Center | 2004-12-01 |
| Effect of a Low-Calorie Diet and/or Exercise Program on Risk Factors for Developing Breast Cancer in Overweight or Obese Postmenopausal Women (NCT00470119) | Fred Hutchinson Cancer Center | 2004-12-01 |
| Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer (NCT00105001) | Fred Hutchinson Cancer Center | 2004-11-01 |
| Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer (NCT00101257) | Fred Hutchinson Cancer Center | 2004-10-01 |
| Promoting Activity and Changes in Eating (PACE) to Reduce Obesity (NCT00119782) | Fred Hutchinson Cancer Center | 2004-09-01 |
| Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies (NCT01056614) | Fred Hutchinson Cancer Center | 2004-09-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00096096) | Fred Hutchinson Cancer Center | 2004-08-01 |
| Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00119392) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00093366) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer (NCT00217529) | Fred Hutchinson Cancer Center | 2004-06-01 |
| Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma (NCT00244855) | Fred Hutchinson Cancer Center | 2004-05-01 |
| Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia (NCT00089050) | Fred Hutchinson Cancer Center | 2004-05-01 |
| Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer (NCT00089011) | Fred Hutchinson Cancer Center | 2004-04-01 |
| Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes (NCT00217386) | Fred Hutchinson Cancer Center | 2004-03-01 |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia (NCT00244829) | Fred Hutchinson Cancer Center | 2004-01-01 |
| Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00075478) | Fred Hutchinson Cancer Center | 2003-10-01 |
| Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant (NCT00078858) | Fred Hutchinson Cancer Center | 2003-09-01 |
| Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer (NCT00248430) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies (NCT00072514) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease (NCT00118326) | Fred Hutchinson Cancer Center | 2003-08-01 |
| Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma (NCT00118339) | Fred Hutchinson Cancer Center | 2003-07-01 |
| Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant (NCT00182663) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation (NCT00089037) | Fred Hutchinson Cancer Center | 2003-06-01 |
| Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant (NCT00068718) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00119366) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma (NCT00317759) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00096161) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer (NCT00062140) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer (NCT00112567) | Fred Hutchinson Cancer Center | 2003-04-01 |
| Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (NCT00060424) | Fred Hutchinson Cancer Center | 2003-03-01 |
| Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00098566) | Fred Hutchinson Cancer Center | 2002-12-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045149) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder (NCT00054340) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma (NCT00054353) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation (NCT00052520) | Fred Hutchinson Cancer Center | 2002-09-01 |
| Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant (NCT00052598) | Fred Hutchinson Cancer Center | 2002-09-01 |
| Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT00217555) | Fred Hutchinson Cancer Center | 2002-07-01 |
| Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission (NCT00045435) | Fred Hutchinson Cancer Center | 2002-04-01 |
| Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment (NCT00079183) | Fred Hutchinson Cancer Center | 2002-04-01 |
| Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation (NCT00045292) | Fred Hutchinson Cancer Center | 2002-04-01 |
| Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients (NCT00082654) | Fred Hutchinson Cancer Center | 2002-03-01 |
| Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease (NCT00032279) | Fred Hutchinson Cancer Center | 2002-03-01 |
| Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer (NCT00049504) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634) | Fred Hutchinson Cancer Center | 2002-01-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045357) | Fred Hutchinson Cancer Center | 2001-11-01 |
| Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies (NCT00040846) | Fred Hutchinson Cancer Center | 2001-11-01 |
| Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone (NCT00006234) | Fred Hutchinson Cancer Center | 2001-11-01 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00027924) | Fred Hutchinson Cancer Center | 2001-10-01 |
| Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer (NCT00897416) | Fred Hutchinson Cancer Center | 2001-10-01 |
| Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00027820) | Fred Hutchinson Cancer Center | 2001-08-01 |
| Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma (NCT00027937) | Fred Hutchinson Cancer Center | 2001-08-01 |
| Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or Nilotinib (NCT00036738) | Fred Hutchinson Cancer Center | 2001-07-13 |
| Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia (NCT00027547) | Fred Hutchinson Cancer Center | 2001-07-01 |
| Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00024050) | Fred Hutchinson Cancer Center | 2001-02-01 |
| Effect of Exercise on Biomarkers of Colon Cancer Risk (NCT00668161) | Fred Hutchinson Cancer Center | 2001-01-01 |
| Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation (NCT00016068) | Fred Hutchinson Cancer Center | 2001-01-01 |
| Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies (NCT00014235) | Fred Hutchinson Cancer Center | 2000-12-01 |
| Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders (NCT00010361) | Fred Hutchinson Cancer Center | 2000-11-01 |
| Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders (NCT00010335) | Fred Hutchinson Cancer Center | 2000-11-01 |
| Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00008151) | Fred Hutchinson Cancer Center | 2000-10-01 |
| Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00012207) | Fred Hutchinson Cancer Center | 2000-09-01 |
| Hutchinson Study of High School Smoking (NCT00115882) | Fred Hutchinson Cancer Center | 2000-09-01 |
| Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors (NCT00004157) | Fred Hutchinson Cancer Center | 2000-08-01 |
| Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00008229) | Fred Hutchinson Cancer Center | 2000-08-01 |
| Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon (NCT00010283) | Fred Hutchinson Cancer Center | 2000-07-01 |
| Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic Sclerosis (NCT00016458) | Fred Hutchinson Cancer Center | 2000-06-01 |
| Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma (NCT00006480) | Fred Hutchinson Cancer Center | 2000-05-01 |
| Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer (NCT00006251) | Fred Hutchinson Cancer Center | 2000-05-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis (NCT00006367) | Fred Hutchinson Cancer Center | 2000-05-01 |
| Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma (NCT00006241) | Fred Hutchinson Cancer Center | 2000-03-01 |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer (NCT00005851) | Fred Hutchinson Cancer Center | 2000-02-01 |
| Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma (NCT00006244) | Fred Hutchinson Cancer Center | 2000-02-01 |
| Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia (NCT00093743) | Fred Hutchinson Cancer Center | 2000-01-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia (NCT00005948) | Fred Hutchinson Cancer Center | 2000-01-01 |
| Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma (NCT00006233) | Fred Hutchinson Cancer Center | 2000-01-01 |
| Biological Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00005853) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Bone Marrow Transplantation in Treating Children With Sickle Cell Disease (NCT00004485) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005854) | Fred Hutchinson Cancer Center | 1999-12-01 |
| Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer (NCT00005941) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer (NCT00112593) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer (NCT00005799) | Fred Hutchinson Cancer Center | 1999-11-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00005804) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00073931) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission (NCT00005940) | Fred Hutchinson Cancer Center | 1999-10-01 |
| Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies (NCT01678443) | Fred Hutchinson Cancer Center | 1999-09-01 |
| Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma (NCT00005803) | Fred Hutchinson Cancer Center | 1999-09-01 |
| Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes (NCT00008177) | Fred Hutchinson Cancer Center | 1999-07-27 |
| Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma (NCT00004158) | Fred Hutchinson Cancer Center | 1999-06-01 |
| Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia (NCT00005802) | Fred Hutchinson Cancer Center | 1999-06-01 |
| Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma (NCT00003954) | Fred Hutchinson Cancer Center | 1999-03-01 |
| Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation (NCT00014391) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia (NCT00003870) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia (NCT00003874) | Fred Hutchinson Cancer Center | 1999-02-01 |
| Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00073918) | Fred Hutchinson Cancer Center | 1999-02-01 |